Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 100.55M $100.55M March 31, 2015
T. Rowe Price Associates 27.94M $4.37B Sept. 30, 2015
Capital Research Global Investors^ 27.41M $4.29B Sept. 30, 2015
Vanguard 24.36M $3.81B Sept. 30, 2015
FMR 14.52M $2.27B Sept. 30, 2015
STATE STREET CORPORATION 8.47M $1.47B March 31, 2015
Jennison Associates 6.86M $1.07B Sept. 30, 2015
Baker Bros. Advisors 6.54M $1.02B Sept. 30, 2015
Sands Capital Management 6.38M $997.75M Sept. 30, 2015
Wells Fargo & Company 6.24M $975.28M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 5.59M $873.77M Sept. 30, 2015
VIKING GLOBAL INVESTORS 5.54M $511.47M June 30, 2013
Ameriprise Financial 5.49M $858.11M Sept. 30, 2015
JPMORGAN CHASE & CO 4.77M $746.66M Sept. 30, 2015
BlackRock Fund Advisors 4.74M $741.79M Sept. 30, 2015

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2011 4.73M $338.08M